Highlight Therapeutics
Highlight Therapeutics develops BO-112, a therapy intended to stimulate immune responses and make tumors more visible to the immune system.
Highlight Therapeutics is a biotech company in Spain.
- Website
- highlighttherapeutics.com
About
Highlight Therapeutics develops BO-112, a therapeutic candidate designed to stimulate a strong immune response against tumors. Its approach seeks to make tumors that are difficult for the immune system to recognize more visible to it, by transforming immunologically cold tumors into immunologically hot tumors.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
- Backend ×1
- Cloud/Infrastructure ×1
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Companies in related industries
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/highlight-therapeutics"><img src="https://indexed.vc/api/badge/company/highlight-therapeutics" alt="Highlight Therapeutics on Indexed.vc" width="260" height="76" /></a>